Keyword: drugmaker

News

Novartis to Close US Generics Unit, Keep Roche Stake

18.10.2017 - As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...

News

Novo Nordisk Settles $58.7 Million in US Fines

08.09.2017 - Danish pharmaceutical producer Novo Nordisk’s US subsidiary is paying nearly $58.7 million to resolve claims that, among other things, it misrepresented a warning by the US Food...

News

Mylan Finalizes US EpiPen Settlement

25.08.2017 - Mylan has finalized a $465 million settlement with the US Department of Justice (DoJ) resolving claims relating to its EpiPen emergency allergy treatment. The DoJ’s announcement of...

News

Teva Cuts Jobs, Closes Plants as Woes Deepen

08.08.2017 - As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...

News

Activist Investor Ackman Exits Valeant

15.03.2017 - US activist investor Bill Ackman is pulling the plug on his Pershing Square Capital Management hedge fund’s loss-making engagement in drugmaker Valeant. After the close of trading...

News

Teva Facing Bribery Charges in Israel

10.02.2017 - Israeli drugmaker – the world’s largest generics producer – has moved into the spotlight again, days after it said it was replacing its CEO Erez Vigodman. According to the Israeli...

News

Teva CEO Erez Vigodman Steps Down

08.02.2017 - Erez Vigodman and the board of Israel’s Teva Pharmaceutical Industries – the world’s largest generics drugmaker – have announced that the chief executive, who has led the company...

News

Novo Nordisk Invests in UK Research Center

01.02.2017 - Novo Nordisk has announced plans to invest 1 billion Danish kroner ($145 million) over 10 years in a new research center at the University of Oxford, giving a major boost to the UK...